Latigo Biotherapeutics Granted FDA Fast Track Designation for LTG-001, Potential Best-in-Class Nav1.8 Inhibitor for the Non-Opioid Treatment of Acute Pain
LTG-001 demonstrated favorable safety and tolerability profile with predictable pharmacokinetics in Phase 1 trial Fast Track designation will facilitate development... Read more.
League and Arcadia Partner to Enable Consumer Health Engagement with AI and Longitudinal Data
Collaboration will enable payers and providers to close care gaps, improve outcomes, and reduce costs LAS VEGAS, March 3, 2025 /PRNewswire/ – League, the... Read more.
HONOR Announces 7 Years of Android OS and Security Updates for the HONOR Magic Series
Extended support allows flagship devices to maintain access to the latest AI innovation and stay secure for longer BARCELONA, Spain, March 3, 2025 /PRNewswire/ —... Read more.
Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Optimized subcutaneous administration of BHV-1300 achieved rapid, deep and sustained lowering of IgG, differentiating Biohaven’s new small molecule class of... Read more.
DeFi Technologies Appoints Chase Ergen to Board of Directors
TORONTO, March 3, 2025 /PRNewswire/ – DeFi Technologies Inc. (the “Company” or “DeFi Technologies“) (CBOE CA: DEFI) (GR: R9B) (OTC:... Read more.
Trinity Capital Inc. Expands Life Sciences Presence to East Coast with John Orlando as Managing Director
PHOENIX, March 3, 2025 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (the “Company”), a leading alternative asset manager, today announced... Read more.
Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a Ph1/2a Trial of PER-001 in Glaucoma Patients at the American Glaucoma Society Meeting
Twenty-four-week data from the Ph1/2a trial in glaucoma patients reveals PER-001 to be well-tolerated. Proof of concept is established with both strong functional... Read more.
Mycom announces commercial availability of MycomEye app to CSPs for instant access to network, service and business data
LONDON, March 3, 2025 /PRNewswire/ — Mycom, a leading independent provider of Network Assurance and Service Experience Assurance solutions to some of the... Read more.
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
Announced acceptance and Priority Review by the United States Food and Drug Administration (FDA) of the new drug application (NDA) for troriluzole in all-genotype... Read more.
Peerbridge Health Unveils Cor MDx™ Next-Generation IoT ECG Wearable at HIMSS Global Health Conference
Wireless connectivity enablement with AT&T helps Peerbridge expand access to AI-driven cardiac care LAS VEGAS, March 3, 2025 /PRNewswire/ — Peerbridge... Read more.